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Abstract
Background—Women with hypertensive disorders in pregnancy are at an increased risk of 
cardiovascular disease and type 2 diabetes later in life. Offspring born from these hypertensive 
pregnancies have increased levels of cardiovascular risk factors; whether they are at an increased 
risk of type 2 diabetes is not known.
Objective—To study the risk of type 2 diabetes in the adult offspring exposed to maternal 
preeclampsia or gestational hypertension in utero.
Study Design—We studied 5335 members of the Helsinki Birth Cohort Study, who were born 
between 1934 and 1944 and who lived in Finland in 1995 when the National Medication Purchase 
Register was initiated. We ascertained gestational hypertension and preeclampsia according to 
modern criteria by using maternal and birth records. We defined type 2 diabetes through purchases 
of antidiabetic medication recorded in the comprehensive National Medication Purchase Register, 
excluding the 31 subjects who had purchased only insulin. We used Cox regression to assess 
hazard ratios for type 2 diabetes.
Results—590 men (21.6%) and 433 women (16.9%) had purchased medication for diabetes. 
Hazard ratio for T2D for offspring exposed to any maternal hypertension in pregnancy was 1.13 
(95% CI 1.00,1.29; n=1780). For maternal gestational hypertension, it was 1.15 (95% CI 1.00, 
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1.33; n=1336) and for preeclampsia 0.98 (0.71, 1.34; n=231). For T2D with first medication 
purchase before 62 years, corresponding hazard ratios were 1.25 (1.04,1.51); 1.28 (1.05,1.58) and 
1.18 (0.75, 1.84). The hazard ratios were similar when adjusted for birth weight SD score for 
gestation, length of gestation, maternal BMI in late pregnancy, height, age and parity and for 
childhood or adult socio-economic position. An increased risk of type 2 diabetes was also 
associated with low birth weight SD score, independent of the association with gestational 
hypertension.
Conclusions—Offspring exposed to maternal gestational hypertension in utero have an 
increased risk of type 2 diabetes in late adult life. This finding underlines the role of the whole 
spectrum of hypertensive disorders of pregnancy as risk factors of offspring disease throughout 
life. It also reinforces previous suggestions that adult healthcare providers should incorporate birth 
histories when evaluating of an individual's risk to develop T2D.
Keywords
birth weight; cardiovascular disease; cerebrovascular disease; diabetes; gestational age; gestational 
hypertension; hypertension; ischemic heart disease; premature; preterm; preeclampsia
Introduction
Hypertensive disorders of pregnancy, including preeclampsia and gestational hypertension, 
are among the most common pregnancy disorders. Women with these conditions have higher 
levels of insulin resistance than women with normotensive pregnancy. This difference 
persists after pregnancy and contributes to a higher risk of type 2 diabetes (T2D) and 
cardiovascular disease in later life. 1–3 Offspring born to these women have also increased 
levels of cardiovascular risk factors such as higher blood pressure4–6 and body mass index4, 
5 and increased risk of manifest disease including stroke7. However, evidence on the 
offspring risk of diabetes is scanty. Studies on premorbid traits such as glucose metabolism 
remain inconclusive.4, 8, 9 Two studies have assessed T2D as an outcome at mean ages of 
473 and 459 years in offspring of mothers with preeclampsia. The association with T2D did 
not reach statistical significance in either study alone3, 9 or a combined analysis;5 neither 
study assessed other hypertensive disorders of pregnancy.
We used the unique data of the Helsinki Birth Cohort Study (HBCS), with maternal 
hypertensive disorders confirmed from pregnancy and birth records using modern criteria,7 
to study their effect on the risk of T2D in offspring born between 1934 and 1944.
Subjects and methods
We studied 6410 singleton members of the HBCS, born between 1934 and 1944, who had 
adequate antenatal clinic and birth hospital data to confirm diagnoses of maternal pregnancy 
disorders by modern criteria as described.7 The specific criteria are shown in Table 1. Birth 
weight SD score, adjusted for gestational age and sex, was based on Finnish standards.10
Of the 6410 cohort members, 5335 lived in Finland in 1995, when the National Medication 
Reimbursement Database was initiated. Based on this database, we defined T2D as at least 
Kajantie et al. Page 2
Am J Obstet Gynecol. Author manuscript; available in PMC 2017 September 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
one purchase of medication for diabetes between 1995 to 2011. Because the early life 
origins of type 1 diabetes are likely to be distinct from those of T2D, we excluded the 31 
subjects who had purchased only insulin, who are likely to have type 1 diabetes. This left us 
with 5304 subjects. Comparisons of these subjects with those who had died or emigrated 
from Finland before 1995 are shown in Supplementary Table 1. Those who had died or 
emigrated were more likely to be men, they were born to younger mothers, and had lower 
and more frequently unknown adult socio-economic position. There was no difference in the 
frequency of hypertensive disorders of pregnancy or in childhood socio-economic position.
The study was approved by the Ethics Committee at Helsinki and Uusimaa Hospital District, 
and data were linked with permission from the Ministry of Social and Health Affairs, 
National Institute for Health and Welfare, and National Social Insurance Institution. We used 
Cox regression, stratified for offspring sex and year of birth, to calculate hazard ratios for 
offspring T2D. Other censoring events were death and migration from Finland, whichever 
occurred first. To allow for non-linear associations with covariates, values of categorical 
covariates with more than two categories (childhood and adulthood socio-economic 
position) were contrasted against an indicator category (lowest socio-economic position). 
Continuous covariates were first entered as first, second and third degree polynomials. As 
this had virtually no effect on the association between hypertensive pregnancy disorders and 
offspring T2D, we report the result adjusted for linear effects of the continuous covariates.
Results
Clinical characteristics are shown in Table 2. 590 men (21.6%) and 433 women (16.9%) had 
purchased medication for diabetes. Mean age at first registered purchase was 61.7 years (SD 
6.0) for men and 63.0 (SD 6.0) years for women. As there was no difference in the 
association between maternal hypertension in pregnancy and T2D between male and female 
offspring (p for interaction >0.3), we report the results pooled for both sexes, stratified for 
sex and year of birth.
Hypertension in pregnancy and T2D in adult offspring
Offspring of mothers with hypertension in pregnancy had a higher risk of developing T2D in 
adult life, compared with offspring of normotensive women (Figure 1). The risk was due to 
an increased risk in offspring of women with gestational hypertension. We then assessed 
these associations separately among those whose first medication purchase for T2D occurred 
before and after 62 years, the approximate mean age of first purchase. We selected this 
cutoff because the medication purchase register started in 1995, when the subjects were aged 
50 to 61 years. The increased risk of T2D was confined to those with first medication 
purchase before 62 years (Figure 1).
There was no association between the risk of T2D and maternal non-severe or severe 
preeclampsia (Figure 1). A post hoc analysis with any maternal preeclampsia combined 
showed hazard ratios of 0.98 (0.71,1.34) for T2D; 1.18 (0.75,1.84) for onset before and 0.83 
(0.53,1.29) after 62 years.
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Prenatal factors and socio-economic status
A one SD higher birth weight SD score was associated with a hazard ratio of 0.87 for T2D 
(95% CI 0.81, 0.93). The risk of T2D was not associated with length of gestation or preterm 
birth (HR 1.18; 0.88, 1.58), although the association with preterm birth before 35 weeks of 
gestation, previously reported in the source cohort.11 approached statistical significance 
(HR 1.60; 0.94, 2.72). The risk of T2D was also not associated with maternal age, height, 
BMI before delivery or parity or with childhood socio-economic position; offspring with 
lower adult socio-economic position had higher rates of T2D. Adjustment for these variables 
had a negligible effect on the association between maternal hypertensive disorders and 
offspring T2D (Table 3).
We then assessed the association between birth weight SD score and adult T2D separately 
among offspring from normotensive and hypertensive pregnancies (Table 4). The association 
appeared stronger among normotensive pregnancies, although the interaction was not 
formally statistically significant. Conversely, the association between maternal gestational 
hypertension and offspring adult T2D was strongest among offspring with the highest birth 
weight SD scores.
Comment
We found that offspring born to mothers with gestational hypertension have higher risk of 
T2D treated by medication than offspring of normotensive mothers. The association was 
limited to T2D with medication initiated before 62 years of age. It was not confounded by 
maternal age or BMI in pregnancy of by childhood socio-economic status. We were unable 
to find any association between maternal preeclampsia and offspring T2D.
We have previously discussed the limitations of the maternal hypertension in pregnancy data 
in the Helsinki Birth Cohort Study.7 A further limitation is that we have no information on 
maternal gestational diabetes or offspring adult BMI, key risks factors of offspring T2D. 
Adjustment for maternal BMI, however, did not change our findings. Moreover, while the 
use of medication purchase data enabled us to distinguish between type 1 and type 2 
diabetes, we could not identify subjects with diabetes treated by diet only or subjects who 
died of emigrated before the register was started in 1995. However, comparisons between 
those who could not be included because of pre-1995 death or migration and those included 
raised little concern over bias. As described,7 a number of mothers had no blood pressure 
recorded before 20 weeks of gestation. Thus the gestational hypertension group is likely also 
to include mothers that today would be classified as having chronic hypertension.
While gestational hypertension predicts subsequent T2D and other chronic diseases in the 
mother, 1 our study is to our knowledge the first to assess its effects on diabetes in adult 
offspring. The hazard ratios, 1.15 for any T2D and 1.34 for T2D before 62 years, are 
relatively modest. Yet, they compare with associations with established adult risk factors 
such as the risk ratio of 1.37 for T2D reported for current smoking.12 For further 
comparison, previously reported hazard ratios of gestational hypertension in this same 
cohort include 1.4 for offspring stroke,7 1.19 for any severe mental disorder and 1.44 for 
severe mood disorder.13
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The lack of association between maternal preeclampsia and offspring T2D should be 
interpreted with caution because of the smaller numbers. However, it is consistent with two 
previous studies that have focused on preeclampsia rather than gestational hypertension as 
an exposure.3, 5, 9 One of these studies was based on the UK 1958 Birth Cohort and 
reported a hazard ratio of 1.19 (95% CI 0.48, 2.96), when the outcome was self-reported 
T2D at 45 years.5, 9 Another study assessed the offspring of mothers who had had pre-
eclampsia in any of their pregnancies, identified T2D cases from medical records in a 
population followed up to 22 to 62 years and reported a hazard ratio of 1.38 (0.89, 2.14).3 In 
the present study, the confidence interval of the 0.98 hazard ratio was (0.71, 1.34); it 
excludes any moderate or large effects with reasonable certainty.
Both low birth weight and gestational hypertension seemed to be independent, additive risk 
factors for offspring T2D. There was, however, some suggestion that the risk associated with 
gestational hypertension might be strongest among those born at high birth weight for 
gestation. This would be consistent with a role of maternal gestational diabetes or 
subthreshold hyperglycaemia, which are associated with gestational hypertension and high 
birth weight.
We conclude that intrauterine exposure maternal gestational hypertension is a novel risk 
factor of type 2 diabetes in adult life. This finding underlines the role of the whole spectrum 
of hypertensive disorders of pregnancy as risk factors of offspring disease throughout life. 
Further, it reinforces previous suggestions that adult healthcare providers should incorporate 
birth histories when evaluating of an individual’s risk to develop T2D.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Hazard ratios and 95% confidence intervals for type 2 diabetes according to exposure to 
maternal hypertensive disorders in pregnancy. The percentages indicate proportion of cohort 
members with type 2 diabetes. “Any hypertension in pregnancy” includes also 213 mothers 
with chronic hypertension.
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